2014
DOI: 10.1378/chest.13-1628
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of Practice Patterns and Quality Gaps in Lung Cancer Staging and Diagnosis

Abstract: Background: Guidelines recommend mediastinal lymph node sampling as the fi rst invasive diagnostic procedure in patients with suspected lung cancer with mediastinal lymphadenopathy without distant metastases. Methods: Patients were a retrospective cohort of 15,316 patients with lung cancer with regional spread without metastatic disease in the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) or Texas Cancer Registry Medicare-linked databases. Patients were categorized based on the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
23
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(25 citation statements)
references
References 27 publications
1
23
1
Order By: Relevance
“…Nodal staging among patients with suspected NSCLC represents guideline-concordant practice 1,2 and is increasingly recognized as a marker of high-quality, high-value oncologic care. 24,25 Our study provides an understanding of the diagnostic value of VEGF-C in a real-world setting.…”
Section: Discussionmentioning
confidence: 94%
“…Nodal staging among patients with suspected NSCLC represents guideline-concordant practice 1,2 and is increasingly recognized as a marker of high-quality, high-value oncologic care. 24,25 Our study provides an understanding of the diagnostic value of VEGF-C in a real-world setting.…”
Section: Discussionmentioning
confidence: 94%
“…In a secondary analysis, EBUS biopsies outperformed conventional bronchoscopy and TTNAguided biopsies in these outcomes as well. It is expected that higher-volume centers would have lower complication rates (3,(12)(13)(14). Previously published data describe an overall lower rate of complications for EBUS-TBNA in comparison to TTNA or conventional transbronchial biopsy; pneumothorax rates have been reported at 0.5%, 4% and 15% for EBUS-TBNA, conventional transbronchial biopsy, and TTNA respectively (5,15,16).…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, some of these procedures cannot evaluate mediastinal nodes and thus are not guideline-consistent, but are still widely used at many institutions. In a recent review of Medicare databases, only 56% of patients had mediastinal sampling before treatment, and only 21% had guideline-consistent diagnostic evaluations (1)(2)(3)(4).…”
Section: Introductionmentioning
confidence: 99%
“…In the current study, the number of patients who received EBUS-TBNA was not documented, and therefore the impact on the results is unknown. There is growing concern that the inconsistent use of guidelines for these procedures is widespread, and may account for the high rates of complications observed in this study and in the literature [26,27].…”
Section: Discussionmentioning
confidence: 82%